Carbamoyl Oxime
Brand names,
Carbamoyl Oxime
Analogs
Carbamoyl Oxime
Brand Names Mixture
Carbamoyl Oxime
Chemical_Formula
CH4N2O2
Carbamoyl Oxime
RX_link
http://www.rxlist.com/cgi/generic2/hydroxyurea.htm
Carbamoyl Oxime
fda sheet
Carbamoyl Oxime
msds (material safety sheet)
Carbamoyl Oxime
Synthesis Reference
No information avaliable
Carbamoyl Oxime
Molecular Weight
76.0547 g/mol
Carbamoyl Oxime
Melting Point
142-146 oC
Carbamoyl Oxime
H2O Solubility
1E+006 mg/L
Carbamoyl Oxime
State
Solid
Carbamoyl Oxime
LogP
-1.432
Carbamoyl Oxime
Dosage Forms
Capsule
Carbamoyl Oxime
Indication
For management of melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and Sickle-cell anemia.
Carbamoyl Oxime
Pharmacology
Hydroxyurea has dose-dependent synergistic activity with cisplatin in vitro. In vivo Hydroxyurea showed activity in combination with cisplatin against the LX-1 and CALU-6 human lung xenografts, but minimal activity was seen with the NCI-H460 or NCI-H520 xenografts. Hydroxyurea was synergistic with cisplatin in the Lewis lung murine xenograft. Sequential exposure to Hydroxyurea 4 hours before cisplatin produced the greatest interaction.
Carbamoyl Oxime
Absorption
Well absorbed from the gastrointestinal tract.
Carbamoyl Oxime
side effects and Toxicity
Oral, mouse: LD50 = 7330 mg/kg; Oral, rat: LD50 = 5760 mg/kg
Carbamoyl Oxime
Patient Information
HYDREA is a medication that must be handled with care. People who are not taking HYDREA should not be
exposed to it. If the powder from the capsule is spilled, it should be wiped up immediately with a damp disposable
towel and discarded in a closed container, such as a plastic bag. The medication should be kept away from children
and pets.
Carbamoyl Oxime
Organisms Affected
Humans and other mammals